ADMA Biologics, Inc.ADMANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR-77.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-77.4%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
202533.35%
2024146.85%
2023152.21%
20222906.39%
2021106.15%
2020-87.80%
201959.72%
2018-293.66%
2017-248.92%
201650.04%